Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative - 25 Studies Found
Recruiting |
: Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT :
|
Recruiting |
: Myeloproliferative Neoplasms (MPNs) Patient Registry :
|
Recruiting |
: Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia :
:
|
Withdrawn |
: Pacritinib in Combination With Low Dose Decitabine in Intermediate-High Risk Myelofibrosis or Myeloproliferative Neoplasm (MPN)/Myelodysplastic Syndrome (MDS) :
|
Completed |
: Tipifarnib in Treating Patients With Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or Undifferentiated Myeloproliferative Disorders :
: |
Withdrawn |
: Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant :
|
Completed |
: Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia :
|
Completed |
: MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia :
: |
Completed |
: Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant :
: |